Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives

British Journal of Cancer

Volumn 99, Issue 10, 2008, Pages 1593-1599

  Kim, J W ^a   Kim, S J ^a   Chung, Y H ^a   Kwon, J H ^a   Lee, H J ^a   Chung, Y J ^a   Kim, Y J ^a   Oh, Do Youn ^a,b   Lee, S H ^a,b   Kim, D W ^a,b   Im, S A ^a,b   Kim, T Y ^a,b   Heo, D S ^a,b   Bang, Y J ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Awareness; Cancer patient; Clinical trial; Perception; Willingness

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; AGE; AGED; ARTICLE; CANCER PATIENT; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PERCEPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SOUTH KOREA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; AWARENESS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; KOREA; MALE; MIDDLE AGED; NEOPLASMS; PATIENT PARTICIPATION; PERCEPTION; PROSPECTIVE STUDIES; REFUSAL TO PARTICIPATE;

EID: 55949118760     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604750     Document Type: Article

References (25)

1. Agrawal M, Grady C, Fairclough DL, Meropol NJ, Maynard K, Emanuel EJ (2006) Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol 24: 4479-4484
2. Christian MC, Trimble EL (2003) Increasing participation of physicians and patients from underrepresented racial and ethnic groups in National Cancer Institute-sponsored clinical trials. Cancer Epidemiol Biomarkers Prev 12: 277s-283s
3. Cobau CD (1994) Clinical trials in the community. The community clinical oncology program experience. Cancer 74: 2694-2700
4. Comis RL, Colaizzi D, Miller JD (2006) Cancer clinical trials (CCT) awareness and attitudes in cancer survivors (Ca surv). J Clin Oncol (Meeting Abstracts) 24: 6061
5. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E (2003) Public attitudes toward participation in cancer clinical trials. J Clin Oncol 21: 830-835
6. Dilts DM, Sandler AB (2006) Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials. J Clin Oncol 24: 4545-4552
7. Ellis PM (2000) Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. Ann Oncol 11: 939-945
8. Gaskin DJ, Kong J, Meropol NJ, Yabroff KR, Weaver C, Schulman KA (1998) Treatment choices by seriously ill patients: the Health Stock Risk Adjustment model. Med Decis Making 18: 84-94
9. Gotay CC (1991) Accrual to cancer clinical trials: directions from the research literature. Soc Sci Med 33: 569-577
10. Haidich AB, Ioannidis JP (2001) Effect of early patient enrollment on the time to completion and publication of randomized controlled trials. Am J Epidemiol 154: 873-880
11. Ho J, Pond G, Newman C, Maclean M, Chen E, Oza A, Siu L (2006) Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital. BMC Cancer 6: 263
12. Kaas R, Hart AAM, Rutgers EJT (2005) The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer. The Breast 14: 310-316
13. Kaluzny A, Brawley O, Garson-Angert D, Shaw J, Godley P, Warnecke R, Ford L (1993) Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program. J Natl Cancer Inst 85: 1945-1950
14. Lara Jr PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS (2001) Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol 19: 1728-1733
15. Lara Jr PN, Paterniti DA, Chiechi C, Turrell C, Morain C, Horan N, Montell L, Gonzalez J, Davis S, Umutyan A, Martel CL, Gandara DR, Wun T, Beckett LA, Chen Jr MS (2005) Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol 23: 9282-9289
16. Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson III AB, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA (2003) Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol 21: 2589-2596
17. Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291: 2720-2726
18. Paterniti DA, Chen Jr MS, Chiechi C, Beckett LA, Horan N, Turrell C, Smith L, Morain C, Montell L, Luis Gonzalez J, Davis S, Lara Jr PN (2005) Asian Americans and cancer clinical trials: a mixed-methods approach to understanding awareness and experience. Cancer 104: 3015-3024
19. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R (1999) Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 52: 1143-1156
20. Sateren WB, Trimble EL, Abrams J, Brawley O, Breen N, Ford L, McCabe M, Kaplan R, Smith M, Ungerleider R, Christian MC (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20: 2109-2117
21. Stiller CA (1994) Centralised treatment, entry to trials and survival. Br J Cancer 70: 352-362
22. Tejeda HA, Green SB, Trimble EL, Ford L, High JL, Ungerleider RS, Friedman MA, Brawley OW (1996) Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 88: 812-816
23. Trimble EL, Carter CL, Cain D, Freidlin B, Ungerleider RS, Friedman MA (1994) Representation of older patients in cancer treatment trials. Cancer 74: 2208-2214
24. Tu SP, Chen H, Chen A, Lim J, May S, Drescher C (2005) Clinical trials: understanding and perceptions of female Chinese-American cancer patients. Cancer 104: 2999-3005
25. Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors Jr AF, Lynn J, Phillips RS (1998) Relationship between cancer patients' predictions of prognosis and their treatment preferences. Jama 279: 1709-1714